Shokoohizadeh Leili, Alvandi Fatemeh, Yadegar Abbas, Azimirad Masoumeh, Hashemi Seyed Hamid, Alikhani Mohammad Yousef
Department of Microbiology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Gastroenterol Hepatol Bed Bench. 2021 Spring;14(2):165-173.
This study was designed to investigate the prevalence of , its toxin-producing genes, and antibiotic resistance patterns in diarrheal samples from hospitalized patients in Hamadan, Iran.
Today, concerns over infection (CDI) have significantly increased due to reduced susceptibility to antibiotics used for CDI treatment. Toxins produced by strains are associated with disease severity and outcome.
In this cross-sectional study, a total of 130 diarrheal samples of patients admitted to different wards of three hospitals in Hamadan from November 2018 to September 2019 were collected. isolates were identified by culture on CCFA and PCR (Polymerase chain reaction). The presence of toxin-encoding genes ( and ) and binary toxin genes ( and ) was analyzed by PCR. Resistance of the isolates to metronidazole, vancomycin and clindamycin antibiotics was determined using agar dilution method.
Out of 130 diarrheal samples from hospitalized patients, 16 (12.3%) isolates were obtained. PCR results were positive for two toxin-producing genes, A and , in all (100%) isolates, and the binary toxin genes A and were detected in 6 (37.5%) and 8 (50%) isolates, respectively. The results of antibiotic susceptibility testing showed resistance to metronidazole, vancomycin, and clindamycin in 3 (18.7%), 3 (18.7%), and 2 (12.5%) isolates, respectively, and all isolates were resistant to rifampicin.
The results of this study showed toxigenic with profile is a major cause of nosocomial diarrhea in Hamadan, and clinical laboratories should routinely perform diagnostic testing on diarrheal specimens of hospitalized patients. Resistance to conventional antibiotic therapy against should be considered as a warning to prevent irrational administration of antibiotics.
本研究旨在调查伊朗哈马丹住院患者腹泻样本中[病原体名称]的流行情况、其产毒基因及抗生素耐药模式。
如今,由于用于治疗[病原体名称]感染(CDI)的抗生素敏感性降低,对CDI的关注显著增加。[病原体名称]菌株产生的毒素与疾病严重程度和转归相关。
在这项横断面研究中,收集了2018年11月至2019年9月期间哈马丹三家医院不同病房收治患者的130份腹泻样本。通过在CCFA上培养及PCR(聚合酶链反应)鉴定[病原体名称]分离株。通过PCR分析毒素编码基因([基因名称1]和[基因名称2])及二元毒素基因([基因名称3]和[基因名称4])的存在情况。采用琼脂稀释法测定分离株对甲硝唑、万古霉素和克林霉素的耐药性。
在130份住院患者腹泻样本中,获得了16株(12.3%)[病原体名称]分离株。PCR结果显示,所有(100%)[病原体名称]分离株的两种产毒基因[基因名称1]和[基因名称2]均呈阳性,二元毒素基因[基因名称3]和[基因名称4]分别在6株(37.5%)和8株(50%)分离株中检测到。抗生素敏感性试验结果显示,分别有3株(18.7%)、3株(18.7%)和2株(12.5%)分离株对甲硝唑、万古霉素和克林霉素耐药,所有分离株均对利福平耐药。
本研究结果表明,具有[特定基因组合]特征的产毒[病原体名称]是哈马丹医院内腹泻的主要原因,临床实验室应常规对住院患者腹泻标本进行[病原体名称]诊断检测。对[病原体名称]常规抗生素治疗的耐药性应被视为防止不合理使用抗生素的警示。